Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates

This study has been terminated.
(Grant funding expired, poor patient enrollment)
Sponsor:
Collaborators:
Children's Research Institute
rEVO Biologics
Information provided by (Responsible Party):
Robert Niebler, Medical College of Wisconsin
ClinicalTrials.gov Identifier:
NCT01158729
First received: June 17, 2010
Last updated: January 16, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)